Insider Actions for Caribou Biosciences Inc.
03/20/2023 |
Rachel E. Haurwitz President and CEO; Director |
10,000 | Derivative/Non-derivative trans. at $2.96 per share. | 29,600 |
01/19/2023 |
Syed Rizvi Chief Medical Officer |
5,627 | Disposition at $6.31 per share. | 35,506 |
12/02/2022 |
Steven B. Kanner Chief Scientific Officer |
21,401 | Derivative/Non-derivative trans. at $2.69 per share. | 57,568 |
10/06/2022 |
Ryan Fischesser VP of Finance and Controller |
2,839 | Derivative/Non-derivative trans. at $4.11 per share. | 11,668 |
10/06/2022 |
Ryan Fischesser VP of Finance and Controller |
2,839 | Derivative/Non-derivative trans. at $2.69 per share. | 7,636 |
10/06/2022 |
Ryan Fischesser VP of Finance and Controller |
10,000 | Disposition at $10.8 per share. | 108,000 |
09/15/2022 |
Barbara G. McClung Chief Legal Officer |
27,518 | Derivative/Non-derivative trans. at $2.69 per share. | 74,023 |
09/15/2022 |
Barbara G. McClung Chief Legal Officer |
77 | Derivative/Non-derivative trans. at $2.69 per share. | 207 |
08/25/2022 |
Steven B. Kanner Chief Scientific Officer |
43,248 | Disposition at $11.22 per share. | 485,242 |
08/25/2022 |
Steven B. Kanner Chief Scientific Officer |
43,248 | Derivative/Non-derivative trans. at $2.69 per share. | 116,337 |
08/22/2022 |
Ryan Fischesser VP of Finance and Controller |
4,848 | Award at $0 per share. | 0 |
05/13/2022 |
Steven B. Kanner Chief Scientific Officer |
6,114 | Derivative/Non-derivative trans. at $2.69 per share. | 16,446 |
05/13/2022 |
Steven B. Kanner Chief Scientific Officer |
68,306 | Derivative/Non-derivative trans. at $1.81 per share. | 123,633 |
05/09/2022 |
Rachel E. Haurwitz President and CEO; Director |
10,000 | Derivative/Non-derivative trans. at $2.96 per share. | 29,600 |
05/05/2022 |
Ryan Fischesser VP of Finance and Controller |
1,138 | Derivative/Non-derivative trans. at $4.11 per share. | 4,677 |
05/05/2022 |
Ryan Fischesser VP of Finance and Controller |
1,136 | Derivative/Non-derivative trans. at $2.69 per share. | 3,055 |